|
FDAAA’s Citizen Petition Reforms Failing to Stem Generic-Halting Hijinks: Study
A provision in the 2007 FDA Amendments Act (FDAAA) intended to limit the use of citizen petitions to block approvals of generic drugs has failed to change the behavior of brand companies, whose use of the petitions continues to rise, according to a new study.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives